Home Page - About the Arthritis Center -Hopkins Rheumatology - Myositis Center - Vasculitis Center - Scleroderma Center
Search for:

























Interleukin-1 Receptor Antagonist
Treatment of Interleukin 1 receptor antagonist in Combination with Methotrexate (MTX) in Rheumatoid Arthritis (RA) Patients S Cohen, E Hurd, JJ Cush, MH Schiff, ME Weinblatt, LW Moreland, M Bear, W Rich, DP McCabe Dallas TX, Denver CO, Boston MA, Birmingham AL, Thousand Oaks CA

Data from a combination therapy with interleukin-1 receptor Antagonist (IL-1ra) and methotrexate (MTX) in rheumatoid arthritis patients were presented both here and at the 1999 American College of Rheumatology meeting. (read the highlights)

 
((top of page)) (next page)

All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.